SARS-CoV2 (COVID-19) Pandemic Control and Prevention
eBook - ePub

SARS-CoV2 (COVID-19) Pandemic Control and Prevention

An Epidemiological Perspective

  1. 166 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

SARS-CoV2 (COVID-19) Pandemic Control and Prevention

An Epidemiological Perspective

About this book

This is the first comprehensive text to provide not only a detailed explanation of how the SARS-CoV2 (COVID-19) virus is spread within human populations, but also an epidemiological analysis and interpretation of viral pandemics to enable better measures for prevention and control.

Providing an introduction to the physiology of both the human immune system and the SARS-CoV2 virus, specifically the virus's replicative potential and our own vulnerability, the book offers an in-depth understanding of how the pandemic evolved. It also highlights the aberrant epigenomic mechanistic process in pathogenic microbe's replication and survival, implying gene and environment interaction that affected different populations. Citing a range of environmental conditions, from structural and systemic racism to malnutrition and low-socioeconomic status, the book examines how these factors exacerbated existing health disparities, resulting in a disproportionate burden of morbidity and mortality on certain social groups.

Also providing invaluable guidance on how future iterations of this pandemic may be better prevented and controlled, this will be a defining book for students, researchers and professionals within Public Health and Clinical Medicine to better understand the SARS-CoV2 (COVID-19) virus, and how to protect the most vulnerable social groups.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access SARS-CoV2 (COVID-19) Pandemic Control and Prevention by Laurens Holmes, Jr. in PDF and/or ePUB format, as well as other popular books in Medicine & Infectious Diseases. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Routledge
Year
2023
Print ISBN
9781032543543
eBook ISBN
9781000957655
Edition
1
Topic
Medicine
Subtopic
Infectious Diseases

Table of contents

  1. Cover
  2. Half Title
  3. Title Page
  4. Copyright Page
  5. Dedication
  6. Table of Contents
  7. Preface
  8. Acknowledgements
  9. Scientific Uncertainties
  10. List of Figures
  11. List of Tables
  12. Explanation of Sections
  13. 1 Immuno-Epidemiologic Perspective in Pathogenic Microbes: Immune System Response and Integration
  14. 2 Immuno-Epidemiologic Perspective in Pathogenic Microbes: Epidemiologic Principles and Concepts
  15. 3 SARS-CoV2 (COVID-19): Pandemic and Public Health Emergency Response
  16. 4 SARS-CoV2 Mutation: Immuno-Epidemiologic and Socio-Epidemiologic Response
  17. 5 COVID-19 Pandemic: Epidemic Curve Down-Drifting and Case Fatality Mitigation
  18. 6 Pregnancy Risk in SARS-CoV2 Transmission and COVID-19 Fetal Survivability: Immuno-Epidemiologic Perspective
  19. 7 SARS-CoV2 (COVID-19) Risk Precipitation and Disproportionate Mortality in African American (AA)/Black Communities
  20. 8 Social Injustice and Systemic Racism: Obstacles to COVID-19 Pandemic Global Health Equity Transformation
  21. 9 SARS-CoV2 “Re-emergence” as COVID-19 (2): Translational Public Health and Immuno-Epidemiologic Response
  22. 10 SARS-CoV2 (COVID-19) Viral Dynamics Control
  23. 11 Immune System Senescence in SARS-CoV2 Transmission and COVID-19 Clinical Manifestations, Severity and Complications
  24. 12 SARS-CoV2 Exponential Spread and COVID-19 Hospitalization, Case Fatality and Mortality: US Pandemic Mitigation and Stabilization Measures Regression
  25. 13 SARS-CoV2 (COVID-19) Synergistic Spread: Conjoint Effect of Personal Responsibility, Control/Preventive Measures and Vaccine Effectiveness
  26. 14 SARS-CoV2 Vaccine versus Vaccination: Immunologic Durability and Community Disproportionate Benefit in the United States and Globally
  27. 15 “COVIDMAS” and SARS-CoV2 (COVID-19) Pandemic Attenuation: Emerging New Strain (Antigenic Subtypes) and Subpopulations Obstacles to Vaccination
  28. 16 SARS-CoV2 (COVID-19) Novel Variants (DELTA), Vaccine Cross-Effectiveness and Durability
  29. 17 SARS-CoV2 (COVID-19) Disproportionate Burden: Hypertension and Mental Health among US Racial/Ethnic Minorities – Blacks/African Americans (AA)
  30. 18 SARS-CoV2 Delta Variant (B.1.617.2) Transmissibility, Subpopulations Case-positivity, Case Fatality and Mortality
  31. 19 Natural Disaster (Hurricane) as Health-related Event in SARS-CoV2 Delta Variant Exponential Transmissibility and Mortality
  32. 20 SARS-CoV2 (COVID-19) Vaccine Effectiveness and Durability in Immunogenic-Related Comorbidities (Multiple Myeloma)
  33. 21 SARS-CoV2 Omicron Variant: Transmissibility, Clinical Manifestations, Severity and Vaccine Effectiveness
  34. 22 SARS-CoV2 Omicron Variant Exponential Transmission and Mitigation Dynamics
  35. 23 SARS-CoV2 (COVID-19) Morbidity Implication in Chronic Disease (Type II Diabetes – T2D) and Pancreatic Carcinoma
  36. 24 Ukraine Invasion and Global SARS-CoV2 (COVID-19) Pandemic Resurgence: Epigenomic Public Health Perspective
  37. 25 SARS-CoV2 (COVID-19) Global Pandemic: “Extreme Epidemiology” Response in Transmission and Case Fatality Stabilization, Mitigation and Control
  38. 26 Black/African Americans (AA) and Disproportionate Burden of SARS-COV-2 (COVID-19) Mortality in the United States
  39. 27 Epidemiologic Risk Modeling of Disproportionate Burden of SARS-CoV2 and COVID-19 Mortality among Racial/Ethnic Minorities (Social Class) in Washington DC, USA
  40. 28 Racial/Ethnic and Geo-Clustering Differentials in SARS-CoV-2 (COVID-19) Cumulative Incidence, Mortality and Temporal Trend in Delaware State, USA
  41. Index